Methicillin-resistant staphylococcus aureus colonization of the groin and risk for clinical infection among HIV-infected adults

Emerging Infectious Diseases

Volumn 19, Issue 4, 2013, Pages 623-629

  Peters, Philip J ^a   Brooks, John T ^a   McAllister, Sigrid K ^a   Limbago, Brandi ^a   Ken Lowery, H ^b   Fosheim, Gregory ^a   Guest, Jodie L ^b   Gorwitz, Rachel J ^a   Bethea, Monique ^b   Hageman, Jeffrey ^a   Mindley, Rondeen ^b   McDougal, Linda K ^a   Rimland, David ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANIMAL CELL; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INGUINAL REGION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; QUESTIONNAIRE; RISK; SKIN INFECTION; SOFT TISSUE INFECTION;

BACTERIA; COLONIZATION; GEORGIA; HIV; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MRSA; STAPHYLOCOCCI; VIRUSES;

ANTI-BACTERIAL AGENTS; ANTI-HIV AGENTS; COINFECTION; GEORGIA; GROIN; HIV; HIV INFECTIONS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NASAL CAVITY; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 84875352100     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1904.121353     Document Type: Article

References (31)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763-71. http://dx.doi. org/10.1001/jama.298.15.1763
2. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9:978-84. http://dx.doi. org/10.3201/eid0908.030089
3. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillinresistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis. 2005;11:928-30. http://dx.doi. org/10.3201/eid1106.040641
4. Skiest D, Brown K, Hester J, Moore T, Crosby C, Mussa HR, et al. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med. 2006;7:361-8. http://dx.doi. org/10.1111/j.1468-1293.2006.00394.x
5. Mathews WC, Caperna JC, Barber RE, Torriani FJ, Miller LG, May S, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr. 2005;40:155-60. http://dx.doi.org/10.1097/01.qai.0000179464.40948.b9
6. Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS. 2007;18:521-6. http://dx.doi.org/10.1258/095646207781439702
7. Hidron AI, Kempker R, Moanna A, Rimland D. Methicillin-resistant Staphylococcus aureus in HIV-infected patients. Infect Drug Resist. 2010;3:73-86. http://dx.doi.org/10.2147/IDR.S7641
8. Thompson K, Torriani F. Community-associated methicillinresistant Staphylococcus aureus in the patient with HIV infection. Curr HIV/AIDS Rep. 2006;3:107-12. http://dx.doi.org/10.1007/ BF02696653
9. Lee NE, Taylor MM, Bancroft E, Ruane PJ, Morgan M, McCoy L, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis. 2005;40:1529-34. http:// dx.doi.org/10.1086/429827
10. Bozzette SA, Joyce G, McCaffrey DF, Leibowitz AA, Morton SC, Berry SH, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med. 2001;344:817-23. http://dx.doi.org/10.1056/ NEJM200103153441107
11. Cenizal MJ, Hardy RD, Anderson M, Katz K, Skiest DJ. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients. J Acquir Immune Defic Syndr. 2008;48:567-71. http://dx.doi. org/10.1097/QAI.0b013e31817e9b79
12. Hidron AI, Kourbatova EV, Halvosa JS, Terrell BJ, McDougal LK, Tenover FC, et al. Risk factors for colonization with methicillinresistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis. 2005;41:159-66. http://dx.doi. org/10.1086/430910
13. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197:1226-34. http://dx.doi. org/10.1086/533494
14. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193:172-9. http://dx.doi.org/10.1086/499632
15. Nguyen MH, Kauffman CA, Goodman RP, Squier C, Arbeit RD, Singh N, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med. 1999;130:221-5.
16. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344:11-6. http://dx.doi.org/10.1056/NEJM200101043440102
17. Szumowski JD, Wener KM, Gold HS, Wong M, Venkataraman L, Runde CA, et al. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIVinfected men who have sex with men. Clin Infect Dis. 2009;49:118-21. http://dx.doi.org/10.1086/599608
18. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751-62. http://dx.doi. org/10.1016/S1473-3099(05)70295-4
19. McAllister SK, Albrecht VS, Fosheim GE, Lowery HK, Peters PJ, Gorwitz R, et al. Evaluation of the impact of direct plating, broth enrichment, and specimen source on recovery and diversity of methicillin-resistant Staphylococcus aureus among HIV-infected outpatients. J Clin Microbiol. 2011; 49:4126-30. http://dx.doi. org/10.1128/JCM.05323-11
20. Peters PJ, Brooks JT, Limbago B, Lowery HK, McAllister SK, Mindley R, et al. Methicillin-resistant Staphylococcus aureus colonization in HIV-infected outpatients is common and detection is enhanced by groin culture. Epidemiol Infect. 2010;139:1-11.
21. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillinresistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113-20. http://dx.doi.org/10.1128/JCM.41.11.5113-5120.2003
22. Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol. 2009;47:1344-51. http://dx.doi.org/10.1128/JCM.02264-08
23. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162:199-200. http://dx.doi.org/10.1093/aje/kwi188
24. Altman DG. Practical statistics for medical research. Boca Raton (FL): Chapman & Hall/CRC; 1991.
25. Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis. 2010;50:979-87. http://dx.doi.org/10.1086/651076
26. Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M, et al. Risk factors and mortality of healthcare-associated and communityacquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2012;18:862-9. http://dx.doi.org/10.1111/j.1469-0691.2011.03679.x
27. Pugliese A, Vidotto V, Beltramo T, Torre D. Phagocytic activity in human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol. 2005;12:889-95.
28. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, et al. Emergence of community-associated methicillinresistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006;42:647-56. http://dx.doi.org/10.1086/499815
29. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362:9-17. http://dx.doi.org/10.1056/NEJMoa0808939
30. Ammerlaan HS, Kluytmans JA, Wertheim HF, Nouwen JL, Bonten MJ. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis. 2009;48:922-30. http://dx.doi.org/10.1086/597291
31. Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and Participants in the CDC Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. March 2006 [cited 2011 Dec 1]. http://www.cdc.gov/mrsa/pdf/MRSA-Strategies-ExpMtgSummary-2006.pdf